Ethical Profile
Mixed.
Not enough information to create an ethical profile.
OnKure Therapeutics, Inc..
OKUR.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
OnKure Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of small molecule drugs to treat patients with cancer. The company's pipeline includes preclinical and clinical-stage drug candidates targeting various cancer-related pathways. Their research and develo...Show More
Similar Companies
Value Scores
Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100
Better Health for All
0
No evidence available to assess OnKure Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess OnKure Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, quantitative evidence was found across the provided articles for any of the KPIs related to Fair Pay & Worker Respect. Information regarding living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rates, pay equity, worker engagement, voluntary turnover, labor violation incidents, insecure contract share, or health insurance coverage for the general workforce was not available.
1
The articles primarily focused on executive compensation details, stock-based awards, and workforce reductions, but did not provide the necessary data points to score against the rubric's quantitative thresholds for these KPIs.Fair Trade & Ethical Sourcing
0
No evidence available to assess OnKure Therapeutics, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No relevant evidence was found for OKUR.US in the provided articles.
1
was an error message, and contained information pertaining to Relay Therapeutics, Inc. (RLAY), not OnKure Therapeutics, Inc. (OKUR.US). 2
Therefore, no KPIs could be scored for OnKure Therapeutics, Inc.Kind to Animals
0
No specific evidence was found regarding OnKure Therapeutics, Inc.'s (OKUR.US) animal welfare practices, policies, or performance across any of the assessed KPIs. The provided articles discuss general regulatory changes within the biopharmaceutical industry, such as the U.S. FDA's plan, announced in April 2025, to phase out animal testing requirements for Investigational New Drug applications, encouraging the use of alternative non-animal testing methods like organoids and organs-on-a-chip.
1
The FDA Modernization Act 2.0, passed in 2022, also opened the door for cell-based assays in preclinical safety evaluations. 2
However, these are industry-wide developments and do not provide specific data points on OKUR.US's actions or current standing.No War, No Weapons
0
The provided articles focus on OnKure Therapeutics' biopharmaceutical merger and financial results, specifically regarding cancer drug development. No information or data points relevant to the company's involvement in arms or defense contracts, dual-use technology, sales to embargoed regimes, peacebuilding investments, or any other metrics related to the 'No War, No Weapons' value are present in the evidence.
Planet-Friendly Business
0
The provided articles, which include a press release on financial results and business highlights, and a LinkedIn post, explicitly state that they do not contain any data relevant to the requested metrics for a planet-friendly business analysis.
1
Consequently, no specific evidence was found to assess OnKure Therapeutics, Inc. against the defined KPIs for Planet-Friendly Business.Respect for Cultures & Communities
0
No evidence available to assess OnKure Therapeutics, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess OnKure Therapeutics, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, concrete data points related to waste management, product recyclability, packaging sustainability, or any other 'Zero Waste & Sustainable Products' metrics for OnKure Therapeutics, Inc. were found in the provided articles.
1
The articles primarily detail financial results, corporate merger information, and clinical trial updates. 2
Own OnKure Therapeutics, Inc.?
Upload your portfolio and see how all your holdings score across 11 ethical dimensions.
Audit My PortfolioAI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.